openPR Logo
Press release

Immuno Oncology Assay Market will experience a noticeable growth during the forecast period 2019-2025

03-03-2021 11:00 AM CET | Health & Medicine

Press release from: Orion Market Research

Immuno Oncology Assay Market

Immuno Oncology Assay Market

Immuno-oncology is the study and development of treatments that leverages the immune system of the body for fighting against cancer. The immune system of a body is a complex network of organs, cells, and molecules that protects the human body from a foreign substance including bacteria and viruses that may lead to the occurring of an infection. Apart from finding and destroying foreign substances, the immune system of the body is capable of locating and attacking abnormal cells. For precision cancer treatments, researchers and scientists are working on the development of new techniques and technologies that can harness the natural defense system of the body for targeting and eradicating cancer cells. The global immuno-oncology assay market size is expected to expand at a significant rate owing to various factors such as increasing adoption of targeted therapy coupled with the rising incidence of cancer. Further, the advancement in technology in molecular diagnostics, extensive R&D in cancer diagnostics, and increasing ongoing clinical trials in immunotherapy further contribute to the growth of the market.

To Request a Sample of our Report on Global Zero Liquid Discharge System Market : https://www.omrglobal.com/request-sample/immuno-oncology-assay-market

Increasing prevalence of cancer is primarily expected to drive the global immuno-oncology assay market over the forecast period. According to the World Health Organization (WHO), the global cancer burden has risen to 18.1 million new cases and 9.6 million mortalities in 2018. Further, the aforementioned organization estimates that 1 in 5 men and 1 in 6 women, across the globe, develop cancer during their lifetime. Moreover, the disease has a mortality rate of nearly 1 in 8 men and 1 in 11 women. Globally, 43.8 million people are alive within 5 years of a cancer diagnosis. The increasing burden of cancer is attributed to various factors such as surging aging population, change in lifestyle, growing incidence and prevalence rate of certain cancer diseases.

(Get 15% Discount on Buying this Report)
Browse for Full Report Description at: https://www.omrglobal.com/industry-reports/immuno-oncology-assay-market

Market Segmentation
Global Immuno-Oncology Assay Market by Technology
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Immunoassays
• Other Technologies (Flow Cytometry)
Global Immuno-Oncology Assay Market by Cancer Type
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Bladder Cancer
• Others
Global Immuno-Oncology Assay Market by Application
• Clinical Diagnostic
• Research

Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World

Company Profiles
• Agilent Technologies, Inc.
• Almac Group Ltd.
• AstraZeneca PLC
• Biodesix, Inc.
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories International, Inc.
• Crown Bioscience Inc.
• F. Hoffmann-La Roche Ltd
• Foundation Medicine, Inc.
• Horizon Discovery Group PLC
• HTG Molecular Diagnostics, Inc.
• Illumina, Inc.
• InSphero AG
• Lunaphore Technologies S.A.
• Merk KGaA
• NANOBIOTEC, LLC
• NanoString Technologies, Inc
• Perkinelmer, Inc.
• Qiagen NV
• Sartorius AG
• Thermo Fisher Scientific Inc.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/immuno-oncology-assay-market

Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immuno Oncology Assay Market will experience a noticeable growth during the forecast period 2019-2025 here

News-ID: 2251347 • Views:

More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Immuno

Evolving Market Trends In The Immuno-Oncology Drugs Industry: Collaborative Inno …
The Immuno-Oncology Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Immuno-Oncology Drugs Market Size During the Forecast Period? The market size for immuno-oncology drugs has experienced a rapid expansion in recent years. Its value is projected to increase from $94.16 billion
Next-Gen Immuno-Oncology Conference | 7th Annual MarketsandMarkets
Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Boston, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register This congress
Organic Dispersion To Drive The Immuno-Oncology Market
The immuno-oncology therapy has shown excellent results in various clinical trials and in patients being treated with immune-oncology therapy. Immuno-oncology therapies can leverage patients' immune system and re-program the same to attack cancer cells, providing a safe and effective alternative. There has been an increasing demand for immuno-oncology therapy as several traditional methods used in the treatment of cancer such as chemotherapy, radiation therapy, and surgery, etc. carry the risk
Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications. The research goes into great detail on several aspects that have been studied as
Next Gen Immuno-Oncology Congress - 4th Annual MarketsandMarkets
In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction. Register as a Delegate at https://www.reportsnreports.com/events/4th-annual-marketsandmarkets-next-gen-immuno-oncology-congress/register o 30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on
Cell Therapy to Transform Immuno Oncology Landscape
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download